Table 1.
Descriptive statistics for 152 PCTs
| Mean | Standard Deviation | Minimum | Maximum | |
|---|---|---|---|---|
| Number of girls eligible | ||||
| Routine | 1,996 | 1,167 | 367 | 7,730 |
| Catch-up | 2,181 | 1,828 | 654 | 7,788 |
| HPV uptake, first dose only, % | ||||
| Routine | 87.6 | 7.5 | 54.0 | 100.0 |
| Catch-up | 60.2 | 16.6 | 7.6 | 97.3 |
| HPV uptake, 2 doses, % | ||||
| Routine | 85.6 | 8.3 | 52.1 | 100.0 |
| Catch-up | 52.2 | 16.3 | 5.5 | 95.7 |
| Deprivation | ||||
| Average IMD score | 23.7 | 9.1 | 8.1 | 48.3 |
| Average rank | 17,569 | 5,340 | 6,177 | 28,396 |
| Extent, % | 23.9 | 19.2 | 0.3 | 81.3 |
| Local concentration | 29,001 | 3,055 | 19,388 | 32,434 |
| Cervical cancer screening uptake, % | ||||
| Ages 25-49 years | 72.2 | 4.7 | 57.9 | 81.2 |
| Ages 50-64 years | 79.3 | 3.1 | 67.8 | 85.2 |
| Childhood immunisation uptake, % | ||||
| DT/IPV, age 5 | 92.7 | 6.4 | 61.5 | 98.8 |
| DTaP/IPV, age 5 | 79.8 | 13.9 | 21.3 | 95.2 |
| MMR1, age 5 | 89.2 | 5.8 | 60.2 | 96.6 |
| MMR2, age 5 | 78.0 | 10.8 | 32.0 | 91.5 |
| DTaP/IPV/Hib, age 2 | 94.0 | 4.9 | 64.0 | 99.4 |
| MMR, age 2 | 84.9 | 6.4 | 56.3 | 94.7 |
| MenC, age 2 | 92.0 | 7.4 | 56.3 | 98.8 |
| Chlamydia screening, % | ||||
| Screening uptake | 16.4 | 5.1 | 4.2 | 35.8 |
| Positive test results | 7.4 | 2.0 | 3.5 | 12.8 |
| Ethnic composition of population, % | ||||
| White | 86.8 | 12.7 | 35.9 | 97.9 |
| Asian | 7.0 | 7.8 | 0.9 | 43.7 |
| Black | 4.2 | 5.2 | 0.5 | 24.1 |
| Other | 2.1 | 1.6 | 0.6 | 8.8 |
| QOF scores, % | ||||
| Clinical | 97.8 | 1.3 | 90.9 | 99.5 |
| Organisation | 95.8 | 2.7 | 84.1 | 99.1 |
| Patient experience | 83.8 | 6.3 | 47.2 | 94.4 |
| Additional services | 97.2 | 3.2 | 83.4 | 100.0 |